Drug Profile
Research programme: Graves' disease therapeutics - Thyritope Biosciences
Alternative Names: Thyroid hormone modulators - Thyritope Biosciences; Thyroid-stimulating antibody inhibitors - Thyritope BiosciencesLatest Information Update: 28 Oct 2018
Price :
$50
*
At a glance
- Originator Thyritope Biosciences
- Class
- Mechanism of Action Thyroid-stimulating immunoglobulin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Graves' disease
Most Recent Events
- 28 Oct 2018 No recent reports of development identified for research development in Graves'-disease in USA
- 22 Sep 2014 Early research in Graves' disease in USA (unspecified route)